APPROVALS

TEPOXX approved in Japan for treatment of orthopoxviruses

SIGA Technologies' antiviral treatment TEPOXX (tecovirimat 200 mg capsules), marketed as TPOXX in the United States, has received regulatory approval in Japan for the treatment of smallpox, mpox, cowpox,...

View the Online Magazine

Latest Issue

Magazine Archive

Launches

Amazon Filters launches high-temp vent filter for pharma and biotech

A UK process filter manufacturer has launched an enhanced high-temperature-resistant membrane product aimed at vent applications across the global pharmaceutical and biotechnology markets. Amazon Filters’...

Merck opens new €290m biosafety testing facility

Merck has opened its new €290 million biosafety testing facility in Rockville, Maryland, USA. Biosafety testing and analytical development are fundamental components of drug...

Beckman Coulter and Scopio Labs add world’s first digital bone marrow imaging and analysis to long-term partnership

Beckman Coulter, a clinical diagnostics leader, and Scopio Labs, a medtech company that develops digital cell morphology workflow solutions, jointly announced the expansion of...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

Er-Kim extends exclusive distribution agreement with Ascendis to expand commercialization of endocrinology portfolio

Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies, has extended its exclusive agreement with Danish biopharmaceutical company Ascendis Pharma to commercialize...

Camida wins Pharma Supplier of the Year!

The much-coveted title, Pharma Supplier of the Year, was bestowed upon Camida at the 2024 Pharma Industry Awards. (Wednesday, 30 October / Dublin, Ireland) Camida...

AscellaHealth acquires CHAPPER healthcare

AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, has acquired CHAPPER healthcare, a global specialty pharmaceutical wholesaler, distributor and...

ProductLife Group strengthens global drug development capabilities with acquisition of IntiQuan

ProductLife Group (PLG), a regulatory, scientific, compliance, and digital transformation consulting services firm for the life sciences industry, has acquired IntiQuan, a Swiss boutique...

Approvals

TEPOXX approved in Japan for treatment of orthopoxviruses

SIGA Technologies' antiviral treatment TEPOXX (tecovirimat 200 mg capsules), marketed as TPOXX in the United States, has received regulatory approval in Japan for the...

GSK’s Nucala approved in China for adults with chronic rhinosinusitis with nasal polyps

The China National Medical Products Administration has approved GSK's Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5), as an add-on therapy with intranasal...

Tarlatamab approved to treat small cell lung cancer

Sotatercept approved to treat adults with pulmonary arterial hypertension

European Commission approves RYBREVANT in combination with LAZCLUZE for the first-line treatment of patients with EGFR-mutated advanced non-small cell lung cancer

Roche’s Vabysmo prefilled syringe approved in EU for three retinal conditions that can cause blindness

Manufacturiung

Finance

Research & Development
Latest

R&D

Candid Therapeutics enters agreement with WuXi Biologics on trispecific T-cell Engager

Candid Therapeutics, a clinical-stage biotechnology company focused on advancing T-cell engagers for autoimmune and inflammatory diseases, has entered an agreement with WuXi Biologics under...
R&D

Innovent Biologics and Roche to advance antibody drug conjugate candidate in advanced small cell lung cancer

Innovent Biologics has announced a collaboration and exclusive license agreement with Roche to advance the development of IBI3009, a novel delta-like ligand 3 (DLL3)-targeted...
R&D

FDA Orphan Drug Designation granted to NMD670 for Charcot-Marie-Tooth disease

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) for NMD Pharma's NMD670, a novel, oral, small molecule inhibitor of...
R&D

Orion and Abilita Therapeutics to develop innovative antibody therapeutics

Orion Corporation and Abilita Therapeutics have entered into a research collaboration and option to license agreement to develop innovative antibody therapeutics in the areas...
R&D

Conduit Pharmaceuticals partners with Sarborg to leverage AI and cybernetics to optimize drug development

Conduit Pharmaceuticals has entered into an agreement with Sarborg to leverage an advanced artificial intelligence (AI) and cybernetics platform to evaluate key deliverables across...

Appointments

© 2021 Part of the Business Link Magazine Group. Armstrong House, Armstrong Street, Grimsby,
North East Lincolnshire, DN31 2QE

About Us

Popular Category

Editor Picks